Alwyn Capital
16+Portfolio
Alwyn Capital invests in early‑stage biotechnology companies developing plant‑based proteins, cultivated meat, fermentation, recombinant technologies and non‑animal materials, including organ‑on‑chip models. They aim to reduce dependence on animals, addressing climate and human health challenges.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 78.6%
- Canada
- 14.3%
- United Kingdom
- 7.1%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 57.1%
- Agriculture Technology
- 35.7%
- Clean Technology
- 35.7%
- Consumer Goods
- 21.4%
- Manufacturing / Industry 4.0
- 14.3%
- Chemical Technology
- 14.3%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
Pre-Seed → Seed
Fund details
Funds
Alwyn Capital Fund I
Vintage 2024